Krisztina Eva Sajosi’s journey from BIA-ALCL diagnosis to international advocacy is both powerful and deeply personal. Today we honor her resilience and commitment to raising global awareness about the hidden risks of breast implants, and her tireless efforts to ensure no woman faces this alone or uninformed.

If you're considering breast reconstruction after breast cancer, this article is a must-read. Carol Small shares her powerful story of regret, health complications, and the critical importance of informed consent.

The PIP breast implant scandal is back in the news thanks to 60 Minutes Australia. Read why this is a powerful reminder that without transparency and independent oversight, the same mistakes can happen again.

A major government just said the quiet part out loud. Cosmetic procedures, including breast implants, come with real risks, and now the UK is launching an official inquiry to investigate. Learn how you can help before the July 4th deadline.

BISA was featured in the Tampa Bay Times alongside brave survivors of BIA-ALCL who gathered in Tampa to advocate for a ban on textured implants, stronger cancer warnings, and national cancer reporting.

If you’ve had breast surgery, you may have had GalaFLEX mesh or the “internal bra” placed in your body without knowing it. Here is what you need to know, why it matters, and what to do about it.

When device risks aren't clearly communicated, patients pay the price. In the wake of sweeping FDA layoffs, BISA spoke out in MedTech Dive about how delayed safety alerts and missing recall notices could put lives at risk.

The MDIC released new guidance on using real-world data. As momentum builds around direct patient input, BISA offers practical recommendations to turn this progress into lasting safety, trust, and meaningful partnerships.

As the medical community discusses the latest on breast implant associated cancers, members of the Breast Implant Safety Alliance (BISA) are gathering patients and survivors to help amplify their powerful stories.

Groundbreaking research confirms that silicone can migrate into the body, even without a rupture, triggering inflammation, immune responses, and autoimmune markers. What does this mean for women with implants? The findings may change everything. Read more to find out.

SAVE THE DATE! The 6th World Consensus Conference on BIA-ALCL will be held April 11-12, 2025, and will feature leading experts in breast surgery and implant safety discussing the latest research on breast implant-associated cancers.

Women with breast implants have long reported lingering health issues—even after removal. Now, groundbreaking research reveals a possible culprit: residual silicone particles left behind in the body, triggering chronic inflammation. Could this be the missing link to unexplained symptoms? Here’s what you need to know.

The FDA plays a major role in deciding which medical devices are safe, but who ensures that patient voices are heard in those decisions? BISA’s own Maria Gmitro has been appointed as a Consumer Representative for the FDA, bringing real-world patient perspectives to the table. Read on to find out why this is a major win for patient advocacy!

Recognized on February 13th, Breast Implant Illness (BII) Awareness Day serves as a critical moment to highlight the struggles faced by individuals experiencing health complications related to breast implants.

On February 6, 2025, the FDA provided updates on the safety and effectiveness of breast implants. BISA provides a brief summary and why this info is crucial for the public.

The FDA recently removed web pages about diversity in clinical trials, medical device safety, and more. Many experts are worried that this will make it harder for people to find important health information.

Are breast implants as safe as we think, and why do we still question the safety? Members of the Breast Implant Safety Alliance (BISA) reviewed a new article examining the reputation of the FDA concerning the safety of breast implants.

BISA’s president Maria Gmitro and BISA’s advisor data advocate Madris Kinard of Device Events were both quoted in MedTech Dive, citing the optimism regarding Dr. Michelle Tarver’s appointment as the new Director of CDRH at FDA.